Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Scan for outdated or missing drivers - takes under a minute3Repair Windows errors before they cause bigger problemsSergey Brin’s reported donations to Parkinson’s research have grown well beyond the $1.1 billion milestone first reported in 2022. Forbes’ profile, updated July 15, 2026, puts his cumulative giving above $2 billion. That is a reported total, not a publicly itemized lifetime ledger: grants have moved through foundations, stock gifts, donor-advised funds and research organizations. The giving has largely backed research, not direct patient payments or a guaranteed cure.
How the $1.1 billion claim changed
On December 9, 2022, Forbes reported that Brin had directed approximately $1.1 billion toward Parkinson’s research. The estimate was attributed to people familiar with his philanthropy; the story did not publish a complete, transaction-by-transaction accounting. The figure described cumulative giving by that date, not a single donation made in 2022. Forbes’ original report
Forbes later reported more than $2 billion in cumulative Parkinson’s giving in its profile updated July 15, 2026. The headline claim is therefore credible as a historical milestone, but $1.1 billion is no longer the latest published estimate. The higher figure should still be attributed to Forbes rather than described as independently audited. Forbes’ Sergey Brin profile
Why Parkinson’s is personal to Brin
Forbes reported that Brin carries an LRRK2 mutation associated with elevated Parkinson’s risk, and that his mother also carries the mutation and was diagnosed with the disease. A risk-associated mutation is not a diagnosis: the available reporting does not say that Brin has Parkinson’s or that he is certain to develop it. Forbes’ 2022 investigation
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →#1 Best Overall
How the giving is routed
The reported total spans more than direct personal checks. Public records and reporting identify the Sergey Brin Family Foundation, Alphabet stock gifts, donor-advised funds and grants routed to organizations such as the Michael J. Fox Foundation (MJFF), as well as research institutions including UCSF and Stanford. These channels matter when comparing totals: a grant may be recorded by the foundation that made it, the intermediary that received it or the program it supports.
Forbes reported that the Brin family foundation gave MJFF $101 million in 2021, and that total Parkinson’s-related giving that year was approximately $233 million. Forbes also reported a $43 million gift to MJFF in 2022. These are historical annual figures, not current annual rates or sums to add to the later cumulative estimate. Forbes’ 2022 investigation
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
Foundation filings offer additional evidence of scale without settling the lifetime total. ProPublica’s indexed data reports $389,463,947 in charitable disbursements by the Sergey Brin Family Foundation in 2023. Indexed 2024 grant records list several large Parkinson’s-related awards, including grants to MJFF, the Aligning Science Across Parkinson’s initiative and UCSF. A 2024 filing index also lists gifts of 471,600 Class A and 471,600 Class C Alphabet shares, valued there at $161,173,654. These records cover particular entities, years and transactions; they should not be treated as a complete accounting of Brin’s lifetime giving or mechanically summed from snippets. ProPublica’s foundation record; indexed foundation filing and grant data; 2024 Form 990-PF
What ASAP funds
Aligning Science Across Parkinson’s, or ASAP, is a collaborative research initiative focused on basic science: understanding Parkinson’s biology and enabling researchers to work across teams. Forbes reported that Brin’s philanthropic team created the entity in 2017 and recruited Nobel laureate Randy Schekman as scientific director and Ekemini Riley as managing director. It is a research initiative, not a drug company or a promise to deliver a cure. Forbes’ 2022 investigation
Recommended Free Tools
MJFF’s 2024 audited financial statements separately identify research restricted for the ASAP program, illustrating how an intermediary can administer program funds. A 2025 Gates Foundation case study said ASAP had awarded approximately $290 million across 35 teams involving 163 team leaders. That is a program-level award figure, not Brin’s personal contribution: it may include funding administered through different channels and should not be equated with his cumulative giving. MJFF’s 2024 audited statements; Gates Foundation science-philanthropy case study
What the money supports—and what it does not
Forbes described Brin’s giving as heavily weighted toward basic research. The distinctions are useful when judging what a large research commitment can accomplish:
Rank #4
- Basic research investigates disease mechanisms, genetics, cells and how Parkinson’s begins or progresses.
- Translational research works to move discoveries toward potential interventions or usable tools.
- Clinical research tests interventions in people.
- Patient services provide care, education, support and quality-of-life programs.
Research on biology, shared infrastructure and collaboration may eventually help treatment development, but it is not the same as paying for care or testing a treatment in patients. No source cited here establishes that Brin’s donations produced a cure or a treatment proven to halt Parkinson’s progression. Funding can yield datasets, tools, biological insights and potential drug targets well before any candidate reaches patients.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What public records can and cannot tell you
There is no single public filing in the cited records that supplies a complete lifetime ledger of all Brin-related Parkinson’s donations. Differences between reported totals can reflect the cutoff date, whether a figure counts pledges or distributed funds, how donated stock was valued, and whether grants through foundations or donor-advised funds are included. Scope also matters: a grant for Parkinson’s specifically is different from broader neurodegenerative research, and not every dollar administered by MJFF or ASAP is Brin’s money.
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
For a reader comparing figures, the clearest distinction is between a reported cumulative estimate, documented grants from a named foundation in a particular year and program-wide awards involving potentially multiple funding sources. They answer different questions and cannot be substituted for one another.
How Brin’s giving fits the wider research effort
Brin’s concentrated support is one part of a broader Parkinson’s research ecosystem. MJFF says it has funded more than $3 billion in research programs to date; that foundation-wide figure is not attributable entirely to Brin. The Parkinson’s Foundation reported awarding more than $4.3 million across 44 research grants in 2025 and said its PD GENEration study had surpassed 30,000 participants. Those figures describe that organization’s work, not Brin-funded activity. Michael J. Fox Foundation; Parkinson’s Foundation 2025 annual report
Large private gifts can support research that might otherwise struggle to attract sustained funding, while also giving donors and their chosen organizations influence over which questions receive attention. The available records establish major grants and a substantial focus on basic science; they do not establish improper influence or show that one donor controls Parkinson’s research as a whole.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
